Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Capital Expenditures (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Capital Expenditures for 16 consecutive years, with $430000.0 as the latest value for Q3 2025.

  • Quarterly Capital Expenditures fell 79.56% to $430000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Sep 2025, down 30.1% year-over-year, with the annual reading at $4.1 million for FY2024, 182.49% up from the prior year.
  • Capital Expenditures for Q3 2025 was $430000.0 at Xtant Medical Holdings, up from $366000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $2.1 million in Q3 2024, with the low at $223000.0 in Q3 2023.
  • Average Capital Expenditures over 5 years is $601842.1, with a median of $484000.0 recorded in 2022.
  • The sharpest move saw Capital Expenditures soared 843.5% in 2024, then crashed 79.56% in 2025.
  • Over 5 years, Capital Expenditures stood at $626000.0 in 2021, then fell by 29.23% to $443000.0 in 2022, then dropped by 18.06% to $363000.0 in 2023, then surged by 85.12% to $672000.0 in 2024, then tumbled by 36.01% to $430000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $430000.0, $366000.0, and $1.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.